CTK Biotech Philippines

09/16/2025

05/24/2025

CTK Biotech and Sta. Ana Healthcare Plus Corporation proudly showcased at the PAMET Midyear Convention 2025!

From May 14–16, 2025, the PAMET Midyear Convention brought professionals together at the CSI Stadia, Dagupan, Pangasinan—and we were there!

CTK Biotech, in partnership with its exclusive Luzon distributor, Sta. Ana Healthcare Plus Corporation, featured our latest diagnostic innovations and healthcare solutions.

Thank you to all who visited our booth and connected with us. Here's to advancing diagnostics and strengthening partnerships in the field of medical technology!

Together, We can!

03/05/2025

🌟 Protect Maternal and Neonatal Health with the CTK Onsite ToRCH Panel! 🌟

🔬 Fast, Accurate, and Essential Testing for Maternal and Neonatal Health! 👶

The CTK Onsite ToRCH Panel is a 5-in-1 diagnostic tool that tests for Toxoplasmosis, Rubella, Cytomegalovirus (CMV), and Herpes Simplex Virus (HSV 1 & 2)—critical infections that can have serious effects on both mothers and newborns.

Why is this test so crucial?
✅ Early Detection Saves Lives: ToRCH infections can cause severe complications during pregnancy, including birth defects, developmental delays, and preterm birth. Timely detection through the CTK Onsite ToRCH Panel enables healthcare providers to take immediate action, minimizing the risks to both mother and baby.

✅ Fast Results, Accurate Diagnosis: Get reliable results in just 30 minutes! With the 5-in-1 panel, you can quickly assess multiple infections in one test, helping healthcare providers make informed decisions right when it matters most.

✅ WHO-Recommended: According to the World Health Organization (WHO), the timely diagnosis and treatment of ToRCH infections is critical in preventing long-term health complications and improving maternal and child health outcomes. The CTK Onsite ToRCH Panel aligns with WHO’s global health priorities to protect vulnerable populations.

🌍 A Global Health Solution: ToRCH infections are a leading cause of maternal and neonatal morbidity worldwide. Early screening and intervention are key to reducing these health risks. The CTK Onsite ToRCH Panel is being used globally to ensure safer pregnancies and healthier newborns.

Key Features of the CTK Onsite ToRCH Panel:

🔹 5-in-1 panel: Tests for Toxoplasmosis, Rubella, CMV, HSV 1, and HSV 2
🔹 Quick and Easy: Results in just 30 minutes
🔹 Ideal for Maternal and Pediatric Care
🔹 WHO-endorsed to improve maternal and child health outcomes
🔹 Affordable & Reliable

👩‍⚕️ Healthcare professionals, clinics, and hospitals, upgrade your diagnostic tools with the CTK Onsite ToRCH Panel and protect the health of mothers and babies. 💪

02/27/2025

Colorectal cancer (CRC) is the 3rd most common cancer, with 1.9 million new cases annually—10% of global cancer diagnoses. While it’s more common in older adults and wealthy nations, CRC is rising in younger populations and less developed regions. Early detection through rapid stool blood tests can identify CRC even in asymptomatic individuals, saving lives. hashtag hashtag hashtag

Learn more at: https://zurl.co/dnf0p

02/27/2025

Active H. pylori infections often cause GI symptoms treated by patients using antacids and PPIs, which can interfere with certain screening tests like the Urea Breath Test. In 10 minutes, the OnSite® H. pylori Ag Rapid Test provides clinicians with accurate results unaffected by common medications, reducing patient burden without compromising reliability.

Learn more at: https://zurl.co/vUF40

02/27/2025

Backed by 20 years of use in clinical and emergency settings, CTK’s range of OnSite® Dengue Rapid Tests use state-of-the-art recombinant analytes to detect and differentiate Dengue IgG/IgM antibodies and NS1 antigens across all four serotypes, providing clinicians with point-of-care diagnostic aids with reproducible quality and a high standard for accuracy.